Posted on 14 April 2015
Tags: big pharma, J&J, Janssen, partnering
Ichor Medical Systems has entered into a product development collaboration and worldwide license agreement with Janssen Pharmaceuticals Read the full story
Posted on 23 March 2015
Tags: big pharma, J&J, Janssen, M&A
Janssen Pharmaceuticals has acquired XO1 Limited Read the full story
Posted on 16 March 2015
Tags: big pharma, financing, Janssen, partnering
Kura Oncology has entered into an agreement with Janssen Pharmaceutica for an exclusive license to develop and commercialize tipifarnib in the field of oncology Read the full story
Posted on 13 January 2015
Tags: big pharma, J&J, Janssen, licensing, partnering
AC Immune has entered into a worldwide exclusive license agreement and research collaboration with Janssen Pharmaceuticals Read the full story
Posted on 29 December 2014
Tags: J&J, Janssen, licensing, partnering
EB Pharma has executed an agreement with Janssen Pharmaceutica for an exclusive license, to tipifarnib in the field of virology and a related, clinical stage back-up compound Read the full story
Posted on 22 December 2014
Tags: blood cancer, J&J, Janssen, macrogenics
Janssen Biotech has inked a global collaboration and licensing agreement with MacroGenics. Read the full story
Posted on 18 December 2014
Tags: big pharma, Janssen, Janssen biotech, partnering
Halozyme Therapeutics has entered into a worldwide Collaboration and License Agreement with Janssen Biotech for the purpose of developing and commercializing products combining proprietary Janssen compounds with Halozyme's ENHANZE technology Read the full story
Posted on 17 December 2014
Tags: J&J, Janssen, partnering
Galapagos has agreed with Janssen Pharmaceutica that Galapagos will regain full and unencumbered rights to the entire GPR84 program Read the full story
Posted on 03 December 2014
Tags: Astellas, big pharma, Janssen, partnering, pharma, termination
Astellas Pharma announced that its license agreement with Janssen Biotech, to develop and commercialize ASP015K, oral Janus Kinase (JAK) inhibitor, will end Read the full story
Posted on 03 December 2014
Tags: big pharma, J&J, Janssen, partnering, pharma
Atreca has entered into a strategic collaboration with Janssen Biotech in which the companies will apply Atreca’s Immune Repertoire Capture technology to autoimmune disease Read the full story